Header Logo

Connection

STEVEN I SHERMAN to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Antibodies, Monoclonal.
STEVEN I SHERMAN
Connection Strength
0.010
Antibodies, Monoclonal
  1. Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes. Asia Pac J Clin Oncol. 2011 Jun; 7 Suppl 2:34-40.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.